Gut Microbial Dysbiosis and Plasma Metabolic Profile in Individuals With Vitiligo

Qingrong Ni,Zhubiao Ye,Yinghan Wang,Jianru Chen,Weigang Zhang,Cuiling Ma,Kai Li,Yu Liu,Ling Liu,Zheyi Han,Tianwen Gao,Zhe Jian,Shuli Li,Chunying Li

DOI: https://doi.org/10.3389/fmicb.2020.592248

IF: 5.2

2020-12-14

Frontiers in Microbiology

Abstract:Autoimmune diseases are increasingly linked to aberrant gut microbiome and relevant metabolites. However, the association between vitiligo and the gut microbiome remains to be elucidated. Thus, we conducted a case-control study through 16S rRNA sequencing and serum untargeted-metabolomic profiling based on 30 vitiligo patients and 30 matched healthy controls. In vitiligo patients, the microbial composition was distinct from that of healthy controls according to the analysis on α- and β-diversity ( P < 0.05), with a characteristic decreased Bacteroidetes: Firmicutes ratio. Meanwhile, the levels of 23 serum metabolites (including taurochenodeoxycholate and L-NG-monomethyl-arginine) in the vitiligo patients were different from those in the healthy individuals and showed significant correlations with some microbial markers. We found that Corynebacterium 1 , Ruminococcus 2 , Jeotgalibaca and Psychrobacter were correlated significantly with disease duration and serum IL-1β level in vitiligo patients. And Psychrobacter was identified as the most predictive features for vitiligo by machine learning analysis (“importance” = 0.0236). Finally, combining multi-omics data and joint prediction models with accuracies up to 0.929 were established with dominant contribution of Corynebacterium 1 and Psychrobacter . Our findings replenished the previously unknown relationship between gut dysbiosis and vitiligo circulating metabolome and enrolled the gut-skin axis into the understanding of vitiligo pathogenesis.

microbiology

What problem does this paper attempt to address?

The paper attempts to address the issue of exploring the dysbiosis of the gut microbiota in vitiligo patients compared to healthy controls and its relationship with plasma metabolites. Specifically, the study compares the gut microbiota composition and plasma metabolic profiles of 30 vitiligo patients and 30 healthy controls through 16S rRNA sequencing and serum untargeted metabolomics analysis. The study found:

1. **Gut Microbiota Dysbiosis**: There is a significant difference in the gut microbiota diversity between vitiligo patients and healthy controls, particularly with a decrease in the ratio of Bacteroidetes to Firmicutes.
2. **Differences in Plasma Metabolites**: 23 serum metabolites showed different levels in vitiligo patients compared to healthy individuals, and these metabolites were significantly correlated with certain microbial markers.
3. **Relationship Between Specific Bacteria and Disease Progression**: The study found that Corynebacterium 1, Ruminococcus 2, Jeotgalibaca, and Psychrobacter were closely related to disease duration and serum IL-1β levels.
4. **Machine Learning Prediction Model**: By combining multi-omics data and joint prediction models, a prediction model with an accuracy of 0.929 was established using Corynebacterium and Psychrobacter as features.

These findings supplement the previously unknown relationship between gut dysbiosis and the circulating metabolome in vitiligo and incorporate the gut-skin axis into the understanding of the pathogenesis of vitiligo.